Platelet aggregation following exposure of phospholipase-treated platelet rich plasma to hydrogen peroxide.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000201:enzymology*; D002374:Catalase / Q000494:pharmacology; D003094:Collagen / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D006861:Hydrogen Peroxide / Q000494:pharmacology*; D008623:Mercaptoethanol / Q000494:pharmacology; D010740:Phospholipases / Q000494:pharmacology*; D010741:Phospholipases A / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D013917:Thrombin / Q000494:pharmacology; D013997:Time Factors
D008623:Mercaptoethanol; D000244:Adenosine Diphosphate; D005665:Furosemide; D003094:Collagen; D006861:Hydrogen Peroxide; D002374:Catalase; D010740:Phospholipases; D010741:Phospholipases A; D013917:Thrombin; D001241:Aspirin; D004837:Epinephrine